Newswire

FDA Commissioner Makary Reflects on Year of Challenges and Achievements

WASHINGTON — Food and Drug Administration Commissioner Marty Makary highlighted the agency’s accomplishments and addressed the “challenging start” to his tenure in a recent speech to staff. This reflection comes as he marks one year since a significant workforce reduction at the Health and Human Services Department, which included the layoff of 3,500 FDA employees.

April 1, the day of the layoffs, also marked Makary’s first day in office, setting a tumultuous tone for his leadership. The FDA staff faced immediate challenges, including disparaging remarks from Health Secretary Robert F. Kennedy Jr., who referred to them as “sock puppets” of the pharmaceutical industry. In light of these difficulties, Makary emphasized the importance of fostering a positive workplace culture, stating, “We had some difficulty here due to some actions just before I came into office.” This focus on culture may be pivotal for the FDA as it navigates ongoing scrutiny and strives to regain the trust of both its workforce and the public.

For investors and analysts: See in seconds what each company actually manufactures, together with its certificates and compliance status. This isn’t marketing language — it’s factual data on APIs, FDFs, dossiers, and direct producer contacts.
Open the full market picture for your next decision →